Related Experiment Video
Updated: May 11, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome
Pediatric Nephrology (Berlin, Germany)
|May 31, 2013
Summary
A new database centralizes COL4A5 gene variants, crucial for diagnosing X-linked Alport syndrome, a progressive kidney failure. This resource aids researchers and clinicians by improving genetic testing accuracy and understanding disease mechanisms.
Area of Science:
- Genetics
- Nephrology
- Bioinformatics
Background:
- X-linked Alport syndrome is a progressive renal disease caused by pathogenic variants in the COL4A5 gene.
- Over 700 COL4A5 variants are published, with an estimated 400 more unpublished in laboratories.
- Accurate genetic information is vital for diagnosis and research.
Purpose of the Study:
- To establish a centralized, publicly accessible database for published and unpublished COL4A5 variants.
- To standardize variant description and pathogenicity assessment for X-linked Alport syndrome.
- To facilitate genetic testing, research, and understanding of collagen IV biochemistry.
Main Methods:
- Utilizing the Leiden Open Variation Database (LOVD) format for variant description.
- Standardizing nomenclature based on the human reference sequence.
- Linking to other COL4A5 mutation databases and bioinformatics resources.
Main Results:
- A comprehensive Web-based database for COL4A5 variants is now available.
- The database includes published, unpublished, non-pathogenic, and recurrent variants.
- Variants are described with standardized nomenclature, pathogenicity, and clinical associations.
Conclusions:
- The COL4A5 variant database improves genetic testing accuracy and efficiency for X-linked Alport syndrome.
- Increased variant data enhances phenotype prediction and understanding of collagen IV.
- This database serves as a model for other inherited renal disease databases.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

